Abstract:Hepatocellular carcinoma is the fifth most common cancer worldwide and the most common malignant tumor of the liver. Transarterial chemoembolization (TACE) is widely used in the treatment of liver tumors and has become the preferred treatment for patients with hepatocellular cancer who are not suitable for surgical or ablative therapies. The technique is based on the observation that most hepatocellular carcinomas are very vascular tumors with a blood supply that is largely or solely derived from the hepatic artery. The procedure permits the local administration of relatively high concentrations of chemotherapeutic drugs and, in addition, impairs the viability of the tumor by reducing its blood supply. Although TACE can decrease the size of the tumor in up to 70% of patients, there is debate as to the optimal chemotherapeutic drug, the method of embolization and the use of newer products such as drug-eluting beads. Although TACE can be repeated on a number of occasions, a potential issue is that occlusion of the arterial blood supply may lead to nourishment of the tumor by portal blood. An example of this phenomenon is illustrated below. A male, aged 69, was admitted to our hospital because of refractory ascites. He was known to have hepatitis B and had been diagnosed with hepatocellular carcinoma 4 years previously. At the time of diagnosis, hepatic arteriography showed that the tumor was supplied by a branch of the right hepatic artery (Figure 1). He was subsequently treated by TACE and had repeat procedures on five occasions. Prior to admission, ascites had increased in severity with a poor response to diuretics and salt restriction. Blood tests revealed a hemoglobin of 76 g/l with minor changes in liver function tests and a normal serum level of alpha fetoprotein. Peritoneal fluid was a transudate (serum-fluid albumin gradient >1.1 g/dl; 11 g/l) and was repeatedly negative for malignant cells. Arterial portography using a computed tomography scan showed signs of portal hypertension and blood flow to the tumor that contained iodized oil (Figure 2 left). Subsequently, the patient had hepatic arteriography and was treated with a transjugular intrahepatic portosystemic shunt (TIPS). Hepatic angiography was entirely normal but direct portal venography prior to insertion of the shunt revealed tumor staining and a prominent gastric coronary vein (Figure 2 right). The TIPS procedure was associated with improvement in ascites. Contributed by

Treatment of Transcatheter Arterial Embolization in a Patient with Arterioportal Shunt

Surgical Treatment of Portal Vein Cavernous Transformation

Embolization of hepatic arterio-portal shunt in patients with HCC complicated by portal vein tumor ;thrombus treated with TACE combined with portal vein stenting：its clinical significance

Short-Term Curative Effect of Interventional Embolism on Primary Liver Carcinoma Complicated with Hepatic Arterioportal Shunting

Acute Pancreatitis Associated Left-Sided Portal Hypertension with Severe Gastrointestinal Bleeding Treated by Transcatheter Splenic Artery Embolization: a Case Report and Literature Review

Imaging characteristics and intervention therapy for hepatic artery-portal vein shunts in patients with primary liver carcinoma

Symptomatic Hepatic Arterioportal Fistula-Related Portal Vein Hypertension

Hepatobiliary and Pancreatic: Hepatocellular Carcinoma Supplied by Portal Blood after Repeated Transcatheter Arterial Chemoembolization

Splenic embolization in treatment of portal vein occlusion deferring liver transplantation

Digital Subtraction Angiography Manifestation and Interventional Therapy of Arteriovenous Shunting in Primary Hepatocellular Carcinoma of Advanced Stage

Digital substruction angiography manifestation and interventional therapy of hepatocellular carcinoma combined with different types of Hepatic arterial-portal venous shunts

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts

Clinical Evaluation of Partial Splenic Embolization on Primary Hepatic Cancer with Portohypertension

Arterioportal Shunts in Patients with Hepatocellular Carcinoma Treated Using Ethanol-Soaked Gelatin Sponge: Therapeutic Effects and Prognostic Factors

Successful Treatment of a Patient with Hepatic Portal Vein Gas after Radiofrequency Ablation of Atrial Fibrillation: A Case Report

Portal, Mesenteric, and Splenic Vein Thromboses after Endovascular Embolization for Gastrointestinal Bleeding Caused by a Splenic Arteriovenous Fistula

Transcatheter Arterial Embolization in the Treatment of Abdominal Bleeding in Patients Being Treated with Open Abdomen Due to Duodenal Fistula

Transjugular Intrahepatic Portosystemic Shunt for Repeated Bleeding of Hemorrhoids Caused by Severe Portal Hypertension with Ectopic Varices: A Case Report

Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplantation in End-Stage Hepatic Alveolar Echinococcosis with Cavernous Transformation

Successful Treatment with Selective and Transplenic Artery Embolization for Small-for-size Syndrome: a Case Report.

Duodenal Variceal Bleeding Secondary to Idiopathic Portal Hypertension Treated with Transjugular Intra-Hepatic Porto-Systemic Shunt Plus Embolization: A Case Report.